Țară: Irlanda
Limbă: engleză
Sursă: HPRA (Health Products Regulatory Authority)
Ibuprofen
Reckitt Benckiser Ireland Ltd
M01AE; M01AE01
Ibuprofen
200 mg/5ml
Oral suspension
Product not subject to medical prescription
Propionic acid derivatives; ibuprofen
Marketed
2010-12-21
PACKAGE LEAFLET: INFORMATION FOR THE USER Nurofen for Children Six Plus Strawberry 200mg/5ml Oral Suspension ibuprofen For use in children from 20kg body weight (6 years) to 40kg body weight (12 years). READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START USING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you • Keep this leaflet. You may need to read it again • Ask your pharmacist if you need more information or advice. • If your child gets any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4 • You must talk to a doctor if your child does not feel better or if your child feels worse after 3 days. IN THIS LEAFLET: 1. What Nurofen for Children is and what it is used for 2. What you need to know before you use Nurofen for Children 3. How to use Nurofen for Children 4. Possible side-effects 5. How to store Nurofen for Children 6. Contents of the pack and other information 1. WHAT NUROFEN FOR CHILDREN IS AND WHAT IT IS USED FOR? Ibuprofen belongs to a group of medicines called Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). These medicines work by changing how the body responds to pain, and high body temperature. This product has been specifically formulated for children as it is given by mouth to: • Reduce fever • Relieve symptoms of mild to moderate pain You must talk to a doctor if your child does not feel better or if your child feels worse after 3 days. 2. WHAT YOU NEED TO KNOW BEFORE YOU USE NUROFEN FOR CHILDREN DO NOT GIVE NUROFEN FOR CHILDREN TO CHILDREN WHO: • Are allergic to ibuprofen or other similar painkillers (NSAIDs) or to any of the other ingredients of this medicine (listed in Section 6) • Have ever suffered from shortness of breath, asthma, a runny nose, swelling on their face and/or hands or hives after using acetylsalicylic acid or other similar pain killers (NSAIDs) • Have ever h Citiți documentul complet
Health Products Regulatory Authority 17 August 2023 CRN00D7K7 Page 1 of 11 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Nurofen for Children Six Plus Strawberry 200 mg/5 ml oral suspension 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each 1ml of oral suspension contains 40mg ibuprofen Excipients with known effects: Maltitol liquid 2226 mg per 5 ml Sodium 9.18 mg (0.40 mmol) per 5 ml Propylene glycol (E 1520): 16.45 mg per 5 ml For the full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Oral suspension. An off-white, viscous suspension with a strawberry flavour. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the short-term symptomatic treatment of mild to moderate pain. For the short-term symptomatic treatment of fever. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology For pain and fever: The daily dosage of Nurofen For Children is 20-30 mg/kg bodyweight in divided doses. Using the measuring device provided this can be achieved as follows: CHILD'S WEIGHT (AGE) QUANTITY AND METHOD OF ADMINISTRATION FREQUENCY IN 24 HOURS 20-29kg (6-9 years) 1 x 200mg/5ml (using the correct end of the spoon once) 3 times 30-40kg (10-12 years) 1 x 300mg/7.5ml (using the spoon twice (5ml and 2.5ml) 3 times Doses should be given approximately every 6 to 8 hours. Notintended for children under 6 years of age or under 20kg. For short-term use only If symptoms worsen medical advice should be sought. If this medicinal product is required for more than 3 days, or if symptoms worsen a doctor should be consulted. Undesirable effects may be minimised by using the lowest effective dose for the shortest duration necessary to control symptoms (see section 4.4). SPECIAL PATIENT GROUPS Renal insufficiency: (see section 5.2) Health Products Regulatory Authority 17 August 2023 CRN00D7K7 Page 2 of 11 No dose reduction is required in patients with mild to moderate impairment to renal function (patients with severe renal insufficiency, see section 4.3). Hepatic insufficiency (see section 5.2): No dose reduction is Citiți documentul complet